191 related articles for article (PubMed ID: 32757727)
1. Major differences in medical and surgical treatment of psoriatic arthritis and rheumatoid arthritis: a comparison of two historic cohorts.
Nystad TW; Fenstad AM; Fevang BT
Scand J Rheumatol; 2020 Jul; 49(4):267-270. PubMed ID: 32757727
[TBL] [Abstract][Full Text] [Related]
2. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
3. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
[TBL] [Abstract][Full Text] [Related]
4. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis.
Kruithof E; Baeten D; De Rycke L; Vandooren B; Foell D; Roth J; Cañete JD; Boots AM; Veys EM; De Keyser F
Arthritis Res Ther; 2005; 7(3):R569-80. PubMed ID: 15899044
[TBL] [Abstract][Full Text] [Related]
5. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG
Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506
[TBL] [Abstract][Full Text] [Related]
6. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
Helliwell PS; Taylor WJ;
J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
Michelsen B; Uhlig T; Sexton J; van der Heijde D; Hammer HB; Kristianslund EK; Wierød A; Bakland G; Rødevand E; Krøll F; Loge JH; Haugeberg G; Kvien TK
Ann Rheum Dis; 2018 Sep; 77(9):1290-1294. PubMed ID: 29875096
[TBL] [Abstract][Full Text] [Related]
8. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
Meng H; Lam SH; So H; Tam LS
Semin Arthritis Rheum; 2024 Apr; 65():152416. PubMed ID: 38368730
[TBL] [Abstract][Full Text] [Related]
10. Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study.
Christensen IE; Lillegraven S; Mielnik P; Bakland G; Loli L; Sexton J; Uhlig T; Kvien TK; Provan SA
Ann Rheum Dis; 2022 Mar; 81(3):398-401. PubMed ID: 34625404
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study.
Lindström U; di Giuseppe D; Exarchou S; Alenius GM; Olofsson T; Klingberg E; Jacobsson L; Askling J; Wallman JK
RMD Open; 2023 May; 9(2):. PubMed ID: 37173095
[TBL] [Abstract][Full Text] [Related]
12. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
[TBL] [Abstract][Full Text] [Related]
13. Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.
Manara M; Caporali R; Favalli EG; Grosso V; Atzeni F; Sarzi Puttini P; Gorla R; Bazzani C; Fusaro E; Pellerito R; Rocchetta PA; Sinigaglia L
Clin Exp Rheumatol; 2017; 35(5):804-809. PubMed ID: 28770712
[TBL] [Abstract][Full Text] [Related]
14. Clinical remission in rheumatoid arthritis and psoriatic arthritis.
Lubrano E; Mesina F; Caporali R
Clin Exp Rheumatol; 2018; 36(5):900-910. PubMed ID: 29600949
[TBL] [Abstract][Full Text] [Related]
15. Contraception methods used by women with rheumatoid arthritis and psoriatic arthritis.
Leverenz DL; Eudy AM; Jayasundara M; Haroun T; McDaniel G; Benjamin Nowell W; Curtis JR; Crow-Hercher R; White W; Ginsberg S; Clowse MEB
Clin Rheumatol; 2019 Apr; 38(4):1207-1212. PubMed ID: 30649682
[TBL] [Abstract][Full Text] [Related]
16. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
[TBL] [Abstract][Full Text] [Related]
17. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
[TBL] [Abstract][Full Text] [Related]
18. A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Glintborg B; Sørensen IJ; Loft AG; Lindegaard H; Linauskas A; Hendricks O; Hansen IMJ; Jensen DV; Manilo N; Espesen J; Klarlund M; Grydehøj J; Dieperink SS; Kristensen S; Olsen JS; Nordin H; Chrysidis S; Dalsgaard Pedersen D; Sørensen MV; Andersen LS; Grøn KL; Krogh NS; Pedersen L; Hetland ML;
Ann Rheum Dis; 2017 Aug; 76(8):1426-1431. PubMed ID: 28473425
[TBL] [Abstract][Full Text] [Related]
19. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity in psoriatic arthritis and rheumatoid arthritis.
Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
